Passa al contenuto
Merck

Rheumatic manifestations of cocaine use.

Current opinion in rheumatology (2012-12-01)
Jonathan Graf
ABSTRACT

Cocaine use is associated with several rheumatic syndromes. This review summarizes these clinical manifestations and highlights recent developments linked to levamisole-adulterated cocaine. Cocaine use has been linked to several distinctive syndromes that can be difficult to distinguish from idiopathic rheumatic diseases. These disorders can range in severity from purely cosmetic damage to organ and/or life-threatening disease that includes sinonasal destruction and vasculitis. Many of these illnesses are associated with antineutrophil cytoplasmic antibodies (cytoplasmic, perinuclear and atypical perinuclear patterns). With the recent introduction of levamisole as a cocaine adulterant, a newly reported syndrome has emerged that is associated with neutropenia, retiform purpura with cutaneous necrosis and autoantibodies consisting of high-titre perinuclear antineutrophil cytoplasmic antibodies (p-ANCAs) with specificities for 'atypical' antigens. Cocaine use is associated with clinical syndromes that closely mimic other primary rheumatic diseases. Given the high prevalence of cocaine use and its adulteration with levamisole, clinicians should be familiar with these rheumatic manifestations in order to avoid misdiagnosis and unnecessary treatment with potentially toxic therapies.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
(−)-Tetramisole hydrochloride, ≥99% (GC)
Prezzi e disponibilità al momento non sono disponibili
Supelco
Levamisol, VETRANAL®, analytical standard
Prezzi e disponibilità al momento non sono disponibili
Supelco
(−)-Levamisole hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Prezzi e disponibilità al momento non sono disponibili
Levamisole hydrochloride, European Pharmacopoeia (EP) Reference Standard
Prezzi e disponibilità al momento non sono disponibili
Levamisole hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Prezzi e disponibilità al momento non sono disponibili